sb 216763 has been researched along with Colorectal Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, DB; Jung, JH; Kang, SE; Kim, H; Kim, SH; Lee, H; Srivastava, SK; Yun, M | 1 |
Phyu, SM; Smith, TAD; Tseng, CC | 1 |
Feng, Y; Lu, H; Mao, D; Qiao, L | 1 |
Bruyneel, E; Dale, T; De Wever, O; Gespach, C; Le Floch, N; Mareel, M; Rivat, C | 1 |
Iyer, NG; Leong, HS; Liu, ET; Tan, J; Yu, Q; Zhuang, L | 1 |
5 other study(ies) available for sb 216763 and Colorectal Neoplasms
Article | Year |
---|---|
Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Cysteine Proteinase Inhibitors; Disease Progression; F-Box-WD Repeat-Containing Protein 7; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; Indoles; Leupeptins; Male; Maleimides; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Phosphorylation; Proto-Oncogene Proteins c-myc; Repressor Proteins; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous | 2018 |
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Choline; Colorectal Neoplasms; Cytidine Diphosphate Choline; Enzyme Inhibitors; Female; Glucose; Glycogen Synthase Kinase 3; Humans; Indoles; Lipid Metabolism; Magnetic Resonance Spectroscopy; Maleimides; Phosphatidylcholines | 2019 |
B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
Topics: Caco-2 Cells; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Cyclin E; Epithelial-Mesenchymal Transition; G1 Phase Cell Cycle Checkpoints; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Ki-67 Antigen; Maleimides; Neoplasm Invasiveness; Oncogene Proteins; Proliferating Cell Nuclear Antigen; Proteins; RNA Interference; RNA, Small Interfering; Wnt Signaling Pathway | 2016 |
The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling.
Topics: Animals; Antibodies, Monoclonal; Axin Protein; Cell Line; Cell Line, Transformed; Cell Line, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Dogs; Epithelial Cells; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycoproteins; Heterotrimeric GTP-Binding Proteins; HT29 Cells; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Neoplasms; Ligands; Lithium Chloride; Maleimides; Matrix Metalloproteinase 7; Neoplasm Invasiveness; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Repressor Proteins; Retroviridae; Signal Transduction; Transcription Factor AP-1; Transcription, Genetic; Wnt Proteins; Wnt2 Protein | 2005 |
Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Topics: Aminophenols; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Colorectal Neoplasms; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; Humans; Indoles; Maleimides; Mitochondria; Protein Conformation; Proto-Oncogene Proteins; RNA Interference; Transcriptional Activation; Tumor Suppressor Protein p53 | 2005 |